Ceasefire in rail pay dispute saves Sydney’s New Year’s Eve
- Asian stocks had a strong 2024 — but this market was the clear winner, thanks to a tech rally
- FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
